BioNTech Outlines 20
BioNTech Outlines 2024 Strategic Priorities at the 42nd Annual J.P. Morgan Healthcare Conference
January 09, 2024 06:45 ET | BioNTech SE
Plans to have ten or more potentially registrational trials by the end of 2024 Preparing to be commercial-ready by the end of 2025 Ended 2023 with approximately €17.5 billion (unaudited) in cash, cash...
BioNTech stellt stra
BioNTech stellt strategische Prioritäten für 2024 auf der 42. jährlichen J.P. Morgan Healthcare-Konferenz vor
January 09, 2024 06:45 ET | BioNTech SE
BioNTech rechnet mit zehn oder mehr laufenden potenziell zulassungsrelevanten Studien bis Ende 2024Der Aufbau kommerzieller Kapazitäten zur Vorbereitung auf Produkteinführungen soll Ende 2025...
Recursion Unveils LO
Recursion Unveils LOWE Drug Discovery Software at the J.P. Morgan Healthcare Conference
January 08, 2024 10:59 ET | Recursion Pharmaceuticals
SAN FRANCISCO, Jan. 08, 2024 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today presented a demonstration...
CITELINE_LOGO_FULL COLOUR_RGB.png
Citeline to Share Exclusive Insights from 42nd Annual J.P. Morgan Healthcare Conference
January 08, 2024 09:00 ET | Citeline
Citeline, a Norstella company, will provide exclusive access, including daily insights, to the 42nd Annual J.P. Morgan Healthcare Conference Jan. 8-11.
Full Logo - OKYO .jpg
OKYO Pharma to Present at the Biotech Showcase Conference in San Francisco, January 8-10, 2024
January 05, 2024 09:30 ET | OKYO Pharma LTD
OKYO Pharma to Present at the Biotech Showcase Conference in San Francisco, January 8-10, 2024
tiziana-logo.png
Tiziana Life Sciences to Present at Biotech Showcase Conference in San Francisco, January 8-10, 2024
January 05, 2024 09:30 ET | Tiziana Life Sciences Ltd.
Tiziana Life Sciences to Present at Biotech Showcase Conference in San Francisco, January 8-10, 2024
AXIAL Logo 2021MAR05.png
Axial Therapeutics to Present at Upcoming Conferences
January 05, 2024 08:05 ET | Axial Therapeutics
WOBURN, Mass., Jan. 05, 2024 (GLOBE NEWSWIRE) -- Axial Therapeutics, a clinical-stage biotechnology company dedicated to the development of gut-targeted, small molecule therapeutics for neurological...
Avita.png
AVITA Medical to Present at the 42nd Annual J.P. Morgan Healthcare Conference
January 04, 2024 09:00 ET | AVITA Medical
AVITA Medical to present at JP Morgan's Annual Healthcare Conference in San Francisco on Thursday, January 11, 2024.
cargo-logo-full-color-rgb-1165px@300ppi.png
CARGO Therapeutics to Present at 42nd Annual J.P. Morgan Healthcare Conference
January 03, 2024 08:05 ET | Cargo Therapeutics, Inc.
SAN MATEO, Calif., Jan. 03, 2024 (GLOBE NEWSWIRE) -- CARGO Therapeutics, Inc. (NASDAQ: CRGX), a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell...
Recursion to Present
Recursion to Present at the 42nd Annual J.P. Morgan Healthcare Conference on January 8
January 03, 2024 08:00 ET | Recursion Pharmaceuticals
SALT LAKE CITY, Jan. 03, 2024 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced that Chris...